ScholarWorks@성균관대학교

초록

Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-025-93466-8, published online 13 March 2025 Ga Won Jeon and Minkyung Oh contributed equally The original version of this Article contained a typesetting error in the citation of References 7 to 19. As a result, in the Introduction: “BPD is a long-term complication that affects not only the respiratory system but also overall growth and development in preterm infants beyond the neonatal period, extending into childhood and adolescence7. Furthermore, severe BPD not only has a high mortality rate but also increases the risk of long-term complications such as respiratory issues, growth delays, and neurodevelopmental impairments8,9,10,11. Efforts to reduce BPD include decreasing the use of endotracheal intubation and invasive ventilators, increasing the use of non-invasive ventilators12, adopting less invasive surfactant administration13, and using postnatal corticosteroids14,15. Additionally, a reduction in infections and sepsis, which are risk factors for BPD, have been observed16. Despite these efforts, BPD rates continue to rise. This raises concerns about whether reduced mortality inevitably leads to an increased incidence of BPD among surviving extremely preterm infants (EPIs, gestational age < 28 weeks)17,18.” now reads, “BPD is a long-term complication that affects not only the respiratory system but also overall growth and development in preterm infants beyond the neonatal period, extending into childhood and adolescence9. Furthermore, severe BPD not only has a high mortality rate but also increases the risk of long-term complications such as respiratory issues, growth delays, and neurodevelopmental impairments10,11,12,13. Efforts to reduce BPD include decreasing the use of endotracheal intubation and invasive ventilators, increasing the use of non-invasive ventilators14, adopting less invasive surfactant administration15, and using postnatal corticosteroids16,17. Additionally, a reduction in infections and sepsis, which are risk factors for BPD, has been observed18. Despite these efforts, BPD rates continue to rise. This raises concerns about whether reduced mortality inevitably leads to an increased incidence of BPD among surviving extremely preterm infants (EPIs, gestational age < 28 weeks)8,19.” Furthermore, in the Discussion section “Similar to the present study, research conducted among EPIs in the Neonatal Research Network, a large multicenter neonatal network, found that while other morbidities decreased, the incidence of BPD increased, along with survival rates for EPIs19. Additionally, comparisons of mortality and morbidity of EPIs between the CNN and the NRNJ revealed that higher survival rates at lower gestational age in Japan may be responsible for the increased rates of BPD and ROP among survivors18.” now reads, “Similar to the present study, research conducted among EPIs in the Neonatal Research Network, a large multicenter neonatal network, found that while other morbidities decreased, the incidence of BPD increased, along with survival rates for EPIs7. Additionally, comparisons of mortality and morbidity of EPIs between the CNN and the NRNJ revealed that higher survival rates at lower gestational age in Japan may be responsible for the increased rates of BPD and ROP among survivors19.” And “The incidence of BPD increased with the prolonged duration of non-invasive ventilation and supplemental oxygen therapy, even with decreased invasive ventilation and increased corticosteroid use17.” now reads, “The incidence of BPD increased with the prolonged duration of non-invasive ventilation and supplemental oxygen therapy, even with decreased invasive ventilation and increased corticosteroid use8.” Finally, in the Methods section “The method of surfactant administration was categorized as invasive (endotracheal intubation and invasive ventilation) or non-invasive [intubation-surfactant-extubation (InSurE), less invasive surfactant administration (LISA), or minimally invasive surfactant therapy (MIST)]13.” now reads, “The method of surfactant administration was categorized as invasive (endotracheal intubation and invasive ventilation) or non-invasive [intubation-surfactant-extubation (InSurE), less invasive surfactant administration (LISA), or minimally invasive surfactant therapy (MIST)]15.” The original Article has been corrected. © The Author(s) 2025.